Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezogabine Effects on Urinary Voiding Function in Partial Onset Seizures
NCT01607346Phase 4Terminated
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of retigabine in epilepsy, sponsored by GSK. Started Mar 2013; status: terminated.
02
Drugs
retigabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01607346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607346.